These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 75686)
21. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
22. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis. Ring J; Seifert J; Anstwurm H; Frick E; Mertin J; Brass B; Backmund H; Lob G Postgrad Med J; 1976; 52(5 Suppl):123-30. PubMed ID: 792844 [TBL] [Abstract][Full Text] [Related]
23. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation. Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232 [TBL] [Abstract][Full Text] [Related]
24. Suppression of secondary immune response by antilymphocyte serum: time relationship between immunization and administration of antilymphocyte serum. Reuben C; Sundaram K; Phondke GP Immunology; 1979 Jan; 36(1):159-64. PubMed ID: 369994 [TBL] [Abstract][Full Text] [Related]
25. [Problems of the effectiveness of antihuman lymphocyte globulin corresponding to its in vitro-effect (author's transl)]. Schwenke H; von Baehr R Allerg Immunol (Leipz); 1978; 24(1):29-35. PubMed ID: 150215 [TBL] [Abstract][Full Text] [Related]
26. [The influence of pretreatment with specific antibodies on Renal Xenograft Rejection (author's transl)]. Stemberger H; Rauhs R; Thetter O; Tamer A; Mayr WR; Kux M Wien Klin Wochenschr; 1978 Mar; 90(6):197-200. PubMed ID: 345629 [TBL] [Abstract][Full Text] [Related]
27. [Blood picture changes following single and prolonged oral application of ALG in the dog]. Seifert J; Roscher E; Ring J; Brendel W Langenbecks Arch Chir; 1975; Suppl():147-51. PubMed ID: 54847 [TBL] [Abstract][Full Text] [Related]
28. Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa. Kawaharajo K; Homma JY Jpn J Exp Med; 1976 Jun; 46(3):155-65. PubMed ID: 822190 [TBL] [Abstract][Full Text] [Related]
29. [About the elimination of thromboagglutinins from anti-lymphocytic serum (author's transl)]. Bednarík T; Májský A; Simek L; Cajthamlová H; Vopatová M Allerg Immunol (Leipz); 1977; 23(1):43-6. PubMed ID: 141875 [TBL] [Abstract][Full Text] [Related]
30. [Studies on the production of anti-human-lymphocyte serum (ALS) in bulls]. Bednarík T; Simek L; Rerábková E; Cajthamlová H; Jezková Z; Kout M Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):40-7. PubMed ID: 50968 [TBL] [Abstract][Full Text] [Related]
31. Effects of anti-lymphocytic globulin in human subjects. Heyworth MF Immunology; 1981 Aug; 43(4):793-802. PubMed ID: 6974131 [TBL] [Abstract][Full Text] [Related]
32. [Antilymphocyte-globulin and cytostatic therapy in the case of sympathetic ophthalmia (author's transl)]. Süveges I; Fekete B; Szegedi G Klin Monbl Augenheilkd; 1976 Aug; 169(2):200-6. PubMed ID: 979044 [TBL] [Abstract][Full Text] [Related]
33. [Comparative study on technics of lymphocytotoxicity: lymphocytotoxicity effects of equime globulin on human antilymphocytes (ALG)]. Imperato S; Manca F; Dessi V; Gremmo A Boll Soc Ital Biol Sper; 1977 Feb; 53(4):285-91. PubMed ID: 71907 [No Abstract] [Full Text] [Related]
35. [Effect of immunosuppressive and cytostatic factors on the immune responses of the body. Communication II. Effect of hydrocortisone on immunologically competent cells (RFC cells and lymphocytes B) in immunized animals (author's transl)]. Kunicka A; Duroś H; Nowakowska K Probl Med Wieku Rozwoj; 1975; 5():45-55. PubMed ID: 1083520 [TBL] [Abstract][Full Text] [Related]
36. Antibody formation to equine anti-lymphocytic globulin (ALG) in man: effect on absorption, distribution and effectiveness of the ALG. Butler WT; Rossen RD; Reisberg MA; Mazow JB; Trentin JJ; Judd KP J Immunol; 1971 Jan; 106(1):1-10. PubMed ID: 5543711 [No Abstract] [Full Text] [Related]
37. [Adverse effects of anti-thymocyte globulin/anti-lymphocyte globulin therapy]. Kobayashi R; Kaneda M; Watanabe N; Iguchi A; Cho Y; Yoshida M; Arioka H; Naito H; Shikano T; Ishikawa Y Rinsho Ketsueki; 1999 Jul; 40(7):531-5. PubMed ID: 10483134 [TBL] [Abstract][Full Text] [Related]
38. [A comparison of the immunosuppressive effect of normal and purified alpha-globulin fraction of human plasma]. Bednarík T; Cajthamlová H; Lostický C Cesk Farm; 1979 Jun; 28(5):210-1. PubMed ID: 92373 [No Abstract] [Full Text] [Related]
39. [Suppression of antibody formation in rabbits by administering the alpha globulin fraction of the human plasma and cyclophosphamide (author's transl)]. Bednarík T; Cajthamlová H Cas Lek Cesk; 1978 Dec; 117(48):1502-4. PubMed ID: 737694 [No Abstract] [Full Text] [Related]
40. Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens. Leleu X; Terriou L; Duhamel A; Moreau AS; Andrieux J; Dupire S; Coiteux V; Berthon C; Micol JB; Guieze R; Facon T; Bauters F Ann Hematol; 2006 Oct; 85(10):711-6. PubMed ID: 16830141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]